Schedule 13D ownership disclosure

ITERUM THERAPEUTICS PLC SHS NEW

Security class unavailable · CUSIP: G6333L101

Event date: 2020-11-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
19,292,768
Percent of class
30.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-20-000532
Form type
SC 13D
Filer
Iterum Therapeutics plc
CIK
CIK 1659323
Filed
Nov 23, 2020
Reporting period
Nov 22, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub